SCHEMBL1660684

SCHEMBL1660684

CC(C)C1(C)CCCC([O])C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10748897 0.76 CYP1A2 (0.37)
SCHEMBL1764904 0.74
SCHEMBL20446697 0.74
SCHEMBL498649 0.74 L3MBTL1 (0.32)
SCHEMBL8508591 0.74
Hydrochloric Acid SCHEMBL10420443 0.72
SCHEMBL3850139 0.72
SCHEMBL23664095 0.72
SCHEMBL27561118 0.72 APLNR (0.42)
SCHEMBL11372186 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012146994-A2 TEMPERATURE MANAGEMENT COMPOSITION KIMBERLY-CLARK WORLDWIDE, INC. (US) 2012-11-01 WO claimed
EP-1171120-A4 METHODS FOR ALLEVIATING DISCOMFORT OF A HOT FLASH AND COMPOSITIONS THEREFOR AVON PROD INC (US) 2004-11-17 EP claimed
JP-2002536069-A 2002-10-29 JP claimed
EP-1171120-A1 METHODS FOR ALLEVIATING DISCOMFORT OF A HOT FLASH AND COMPOSITIONS THEREFOR AVON PRODUCTS, INC. (US) 2002-01-16 EP claimed
WO-2000045815-A1 METHODS FOR ALLEVIATING DISCOMFORT OF A HOT FLASH AND COMPOSITIONS THEREFOR AVON PRODUCTS, INC. (US) 2000-08-10 WO claimed
EP-4203903-A1 METHODS OF ENHANCING NATURAL DEFENSE IN THE ORAL CAVITY Colgate-Palmolive Company (US) 2023-07-05 EP disclosed
EP-3883541-A1 ORAL CARE COMPOSITIONS COMPRISING A POLYVINYL CAPRALACTAM-POLYVINYL ACETATE-POLYETHYLENE GLYCOL GRAFT COPOLYMER, AND METHODS FOR THE SAME Colgate-Palmolive Company (US) 2021-09-29 EP disclosed
CN-108473484-B Compounds useful as TRPM8 modulators 弗门尼舍公司 2021-06-29 CN disclosed
WO-2021102896-A1 ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2021-06-03 WO disclosed
EP-3723705-A1 COMPOSITIONS COMPRISING PH-SENSITIVE MICROCAPSULES Colgate-Palmolive Company (US) 2020-10-21 EP disclosed
WO-2020139597-A1 ORAL CARE COMPOSITIONS COMPRISING A POLYVINYL CAPRALACTAM-POLYVINYL ACETATE-POLYETHYLENE GLYCOL GRAFT COPOLYMER, AND METHODS FOR THE SAME COLGATE-PALMOLIVE COMPANY (US) 2020-07-02 WO disclosed
WO-2019117890-A1 COMPOSITIONS COMPRISING PH-SENSITIVE MICROCAPSULES COLGATE-PALMOLIVE COMPANY (US) 2019-06-20 WO disclosed
EP-0977553-A1 THROAT SOOTHING COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2000-02-09 EP disclosed
WO-1998047482-A1 THROAT SOOTHING COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1998-10-29 WO disclosed
WO-1998011867-A1 ORAL COMPOSITIONS CONTAINING A ZINC COMPOUND WARNER-LAMBERT COMPANY (US) 1998-03-26 WO disclosed
EP-0801555-A1 ORAL COMPOSITIONS CONTAINING DIMETHICONE COPOLYOLS THE PROCTER & GAMBLE COMPANY (US) 1997-10-22 EP disclosed
WO-1996019190-A1 ORAL COMPOSITIONS CONTAINING DIMETHICONE COPOLYOLS THE PROCTER & GAMBLE COMPANY (US) 1996-06-27 WO disclosed
EP-0696190-A1 NASAL AROMATIC RELEASING COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1996-02-14 EP disclosed
WO-1994025003-A1 NASAL AROMATIC RELEASING COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1994-11-10 WO disclosed
EP-0122038-A1 7-Oxabicycloheptane prostaglandin intermediates and method for preparing same E.R. Squibb &amp; Sons, Inc. (US) 1984-10-17 EP disclosed